PrEP

June 18th 2025

Lenacapavir becomes the first and only twice-yearly option for HIV prevention.

March 20th 2025

As HIV treatment and prevention evolve, the use of long-acting injectables and their role in combating the HIV epidemic grows.

March 17th 2025

Data from conference abstracts and presentations indicate that both preexposure prophylaxis methods continue to demonstrate efficacy.

January 9th 2025

Pharmacists' accessibility and expertise in medication management make them ideal health care providers to discuss prevention strategies, medication adherence, and potential adverse effects.